Back

Why should we treat mitral regurgitation?

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living? Valvular heart disease HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Michele Senni

Papa Giovanni XXIII Hospital, Bergamo (Italy)

5 More presentations in this session

Presentation thumbnail
Introduction.
Professor F. Ruschitzka (Zurich, CH)
Presentation thumbnail
Functional mitral regurgitation patients: when to treat them with transcatheter mitral valve repair?
Professor O. Alfieri (Milan, IT)
Presentation thumbnail
More than 30000 patients treated with transcatheter mitral valve repair, can we talk about survival benefit?
Professor R. von Bardeleben (Mainz, DE)
Presentation thumbnail
Functional mitral regurgitation patients: how transcatheter mitral valve repair improve their quality of life?
Professor J. Trochu (Nantes, FR)
Presentation thumbnail
Take home message.
Professor F. Ruschitzka (Zurich, CH)

Access the full session

Session thumbnail
Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living?

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources